Browse studies

Find your next paid study

5 recruiting studies matching your filters

Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)

Cushing syndrome (CS) is an endocrine disorder caused by chronic exposure to glucocorticoid (GC) excess. Endogenous CS has an estimated incidence of 0.2 to 5.0…

Cushing Syndrome

Estimated

~$10 – $750

Mayo ClinicNCT04543253

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

The major goal of this study is to determine the incidence of adrenal insufficiency in patients with endogenous Cushing syndrome receiving osilodrostat treatme…

Endogenous Cushing SyndromeAdrenal InsufficiencyHypercortisolism

Estimated

~$10 – $750

University of MichiganNCT06430528

Phase 2

Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome

Background: Cushing syndrome (CS) is a set of diseases that develop when the body produces too much adrenocorticotropic hormone (ACTH). ACTH stimulates the pr…

Cushing Syndrome

Estimated

~$10 – $5,625

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT06635629

Treatment Outcomes for Patients With Cushing's Syndrome: a Prospective Data Collection Study

The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long t…

Cushing's DiseaseCushing SyndromeCushing Disease

Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT03364803

Phase 2

A Phase II, Multicenter, Open-label, Non-comparative Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Osilodrostat in Children and Adolescent Patients With Cushing's Syndrome

Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent …

Cushing Syndrome

Estimated

~$10 – $7,500

RECORDATI GROUPNCT03708900